Loading...

Luke Gilbert, PhD

TitleAssistant Professor
SchoolUCSF School of Medicine
DepartmentUrology
Address1450 Third St
San Francisco CA 94158
Phone415-514-4827
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Adamson B, Norman TM, Jost M, Cho MY, Nuñez JK, Chen Y, Villalta JE, Gilbert L, Horlbeck MA, Hein MY, Pak RA, Gray AN, Gross CA, Dixit A, Parnas O, Regev A, Weissman JS. A Multiplexed Single-Cell CRISPR Screening Platform Enables Systematic Dissection of the Unfolded Protein Response. Cell. 2016 Dec 15; 167(7):1867-1882.e21. PMID: 27984733.
      View in: PubMed
    2. Horlbeck MA, Gilbert L, Villalta JE, Adamson B, Pak RA, Chen Y, Fields AP, Park CY, Corn JE, Kampmann M, Weissman JS. Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation. Elife. 2016 Sep 23; 5. PMID: 27661255.
      View in: PubMed
    3. Bent EH, Gilbert L, Hemann MT. A senescence secretory switch mediated by PI3K/AKT/mTOR activation controls chemoprotective endothelial secretory responses. Genes Dev. 2016 Aug 15; 30(16):1811-21. PMID: 27566778; PMCID: PMC5024680 [Available on 02/15/17].
      View in: PubMed, PubMed Central
    4. Nguyen DP, Miyaoka Y, Gilbert L, Mayerl SJ, Lee BH, Weissman JS, Conklin BR, Wells JA. Ligand-binding domains of nuclear receptors facilitate tight control of split CRISPR activity. Nat Commun. 2016 Jul 01; 7:12009. PMID: 27363581; PMCID: PMC4932181.
      View in: PubMed, PubMed Central
    5. Braun CJ, Bruno PM, Horlbeck MA, Gilbert L, Weissman JS, Hemann MT. Versatile in vivo regulation of tumor phenotypes by dCas9-mediated transcriptional perturbation. Proc Natl Acad Sci U S A. 2016 07 05; 113(27):E3892-900. PMID: 27325776; PMCID: PMC4941480 [Available on 01/05/17].
      View in: PubMed, PubMed Central
    6. Deans RM, Morgens DW, Ökesli A, Pillay S, Horlbeck MA, Kampmann M, Gilbert L, Li A, Mateo R, Smith M, Glenn JS, Carette JE, Khosla C, Bassik MC. Parallel shRNA and CRISPR-Cas9 screens enable antiviral drug target identification. Nat Chem Biol. 2016 May; 12(5):361-6. PMID: 27018887; PMCID: PMC4836973.
      View in: PubMed, PubMed Central
    7. Kamiyama D, Sekine S, Barsi-Rhyne B, Hu J, Chen B, Gilbert L, Ishikawa H, Leonetti MD, Marshall WF, Weissman JS, Huang B. Versatile protein tagging in cells with split fluorescent protein. Nat Commun. 2016 Mar 18; 7:11046. PMID: 26988139; PMCID: PMC4802074.
      View in: PubMed, PubMed Central
    8. Horlbeck MA, Witkowsky LB, Guglielmi B, Replogle JM, Gilbert L, Villalta JE, Torigoe SE, Tjian R, Weissman JS. Nucleosomes impede Cas9 access to DNA in vivo and in vitro. Elife. 2016 Mar 17; 5. PMID: 26987018; PMCID: PMC4861601.
      View in: PubMed, PubMed Central
    9. Mandegar MA, Huebsch N, Frolov EB, Shin E, Truong A, Olvera MP, Chan AH, Miyaoka Y, Holmes K, Spencer CI, Judge LM, Gordon DE, Eskildsen TV, Villalta JE, Horlbeck MA, Gilbert L, Krogan NJ, Sheikh SP, Weissman JS, Qi LS, So PL, Conklin BR. CRISPR Interference Efficiently Induces Specific and Reversible Gene Silencing in Human iPSCs. Cell Stem Cell. 2016 Apr 07; 18(4):541-53. PMID: 26971820; PMCID: PMC4830697 [Available on 04/07/17].
      View in: PubMed, PubMed Central
    10. Kampmann M, Horlbeck MA, Chen Y, Tsai JC, Bassik MC, Gilbert L, Villalta JE, Kwon SC, Chang H, Kim VN, Weissman JS. Next-generation libraries for robust RNA interference-based genome-wide screens. Proc Natl Acad Sci U S A. 2015 Jun 30; 112(26):E3384-91. PMID: 26080438; PMCID: PMC4491794.
      View in: PubMed, PubMed Central
    11. Zalatan JG, Lee ME, Almeida R, Gilbert L, Whitehead EH, La Russa M, Tsai JC, Weissman JS, Dueber JE, Qi LS, Lim WA. Engineering complex synthetic transcriptional programs with CRISPR RNA scaffolds. Cell. 2015 Jan 15; 160(1-2):339-50. PMID: 25533786; PMCID: PMC4297522.
      View in: PubMed, PubMed Central
    12. Gilbert L, Horlbeck MA, Adamson B, Villalta JE, Chen Y, Whitehead EH, Guimaraes C, Panning B, Ploegh HL, Bassik MC, Qi LS, Kampmann M, Weissman JS. Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation. Cell. 2014 Oct 23; 159(3):647-61. PMID: 25307932; PMCID: PMC4253859.
      View in: PubMed, PubMed Central
    13. Tanenbaum ME, Gilbert L, Qi LS, Weissman JS, Vale RD. A protein-tagging system for signal amplification in gene expression and fluorescence imaging. Cell. 2014 Oct 23; 159(3):635-46. PMID: 25307933; PMCID: PMC4252608.
      View in: PubMed, PubMed Central
    14. Chen B, Gilbert L, Cimini BA, Schnitzbauer J, Zhang W, Li GW, Park J, Blackburn EH, Weissman JS, Qi LS, Huang B. Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system. Cell. 2013 Dec 19; 155(7):1479-91. PMID: 24360272; PMCID: PMC3918502.
      View in: PubMed, PubMed Central
    15. Larson MH, Gilbert L, Wang X, Lim WA, Weissman JS, Qi LS. CRISPR interference (CRISPRi) for sequence-specific control of gene expression. Nat Protoc. 2013 Nov; 8(11):2180-96. PMID: 24136345; PMCID: PMC3922765.
      View in: PubMed, PubMed Central
    16. Gilbert L, Larson MH, Morsut L, Liu Z, Brar GA, Torres SE, Stern-Ginossar N, Brandman O, Whitehead EH, Doudna JA, Lim WA, Weissman JS, Qi LS. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell. 2013 Jul 18; 154(2):442-51. PMID: 23849981; PMCID: PMC3770145.
      View in: PubMed, PubMed Central
    17. Qi LS, Larson MH, Gilbert L, Doudna JA, Weissman JS, Arkin AP, Lim WA. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell. 2013 Feb 28; 152(5):1173-83. PMID: 23452860; PMCID: PMC3664290.
      View in: PubMed, PubMed Central
    18. Pritchard JR, Bruno PM, Gilbert L, Capron KL, Lauffenburger DA, Hemann MT. Defining principles of combination drug mechanisms of action. Proc Natl Acad Sci U S A. 2013 Jan 08; 110(2):E170-9. PMID: 23251029; PMCID: PMC3545813.
      View in: PubMed, PubMed Central
    19. Gilbert L, Hemann MT. Context-specific roles for paracrine IL-6 in lymphomagenesis. Genes Dev. 2012 Aug 01; 26(15):1758-68. PMID: 22855834; PMCID: PMC3418592.
      View in: PubMed, PubMed Central
    20. Pritchard JR, Gilbert L, Meacham CE, Ricks JL, Jiang H, Lauffenburger DA, Hemann MT. Bcl-2 family genetic profiling reveals microenvironment-specific determinants of chemotherapeutic response. Cancer Res. 2011 Sep 01; 71(17):5850-8. PMID: 21784872; PMCID: PMC3165087.
      View in: PubMed, PubMed Central
    21. Gilbert L, Hemann MT. Chemotherapeutic resistance: surviving stressful situations. Cancer Res. 2011 Aug 01; 71(15):5062-6. PMID: 21771909; PMCID: PMC3148403.
      View in: PubMed, PubMed Central
    22. Gilbert L, Hemann MT. DNA damage-mediated induction of a chemoresistant niche. Cell. 2010 Oct 29; 143(3):355-66. PMID: 21029859; PMCID: PMC2972353.
      View in: PubMed, PubMed Central
    23. DeRocher AE, Coppens I, Karnataki A, Gilbert L, Rome ME, Feagin JE, Bradley PJ, Parsons M. A thioredoxin family protein of the apicoplast periphery identifies abundant candidate transport vesicles in Toxoplasma gondii. Eukaryot Cell. 2008 Sep; 7(9):1518-29. PMID: 18586952; PMCID: PMC2547066.
      View in: PubMed, PubMed Central
    24. Gilbert L, Ravindran S, Turetzky JM, Boothroyd JC, Bradley PJ. Toxoplasma gondii targets a protein phosphatase 2C to the nuclei of infected host cells. Eukaryot Cell. 2007 Jan; 6(1):73-83. PMID: 17085638; PMCID: PMC1800361.
      View in: PubMed, PubMed Central
    Luke's Networks
    Concepts
    Derived automatically from this person's publications.
    See all (136) concept(s)
    _
    Co-Authors
    People in Profiles who have published with this person.
    See all (20) people
    _
    Related Authors
    People who share related concepts with this person.
    See all (60) people
    _
    Back to TOP